SEKISUI Diagnostics
Brittany B. currently serves as a Clinical Research Coordinator at SEKISUI Diagnostics since August 2023. Previously, Brittany held the position of Clinical Translational Research Coordinator I at Vanderbilt University Medical Center from September 2021 to June 2023, successfully managing studies funded by the NIA, including the CHAMP and ADNI-3 studies, and contributing to the AHEAD study. Key responsibilities included study start-up for the ADNI-4 study, training staff, ensuring compliance with regulatory requirements, and overseeing participant interactions and data management. Prior experiences include roles as an Office Assistant at Brower Psychological Police & Public Safety Services, a Teaching Assistant and Resident Assistant at the University of San Diego, and an Investigative Intern. Brittany holds a Bachelor of Arts degree in Behavioral Neuroscience from the University of San Diego, completed in 2020.
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals